Page 82 - Read Online
P. 82
Stojkovska Docevska et al. Rare Dis Orphan Drugs J 2023;2:14 https://dx.doi.org/10.20517/rdodj.2023.09 Page 17 of 17
131. Novinec M, Korenč M, Caflisch A, Ranganathan R, Lenarčič B, Baici A. A novel allosteric mechanism in the cysteine peptidase
cathepsin K discovered by computational methods. Nat Commun 2014;5:3287. DOI PubMed
132. Panwar P, Søe K, Guido RV, Bueno RV, Delaisse JM, Brömme D. A novel approach to inhibit bone resorption: exosite inhibitors
against cathepsin K. Br J Pharmacol 2016;173:396-410. DOI PubMed PMC
133. Sanchez MI, de Vries LE, Lehmann C, et al. Identification of plasmodium dipeptidyl aminopeptidase allosteric inhibitors by high
throughput screening. PLoS One 2019;14:e0226270. DOI PubMed PMC
134. McClung MR, O'Donoghue ML, Papapoulos SE, et al; LOFT Investigators. Odanacatib for the treatment of postmenopausal
osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT extension study. Lancet
Diabetes Endo 2019;7:899-911. DOI PubMed
